Exelixis Clinical Site #111 — Dallas, Texas

Exelixis Clinical Site #111 is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Exelixis Clinical Site #111 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC).

Sponsors: Exelixis.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Exelixis Clinical Site #111?

Exelixis Clinical Site #111 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Exelixis Clinical Site #111 conducted?

Exelixis Clinical Site #111 has 1 clinical trials on record, with 1 currently active. Their work covers Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC).

Is Exelixis Clinical Site #111 accredited by Crixeo Health?

Exelixis Clinical Site #111 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Exelixis Clinical Site #111?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.